{"gene":"PTPN5","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1996,"finding":"STEP61 is an intrinsic membrane protein of striatal neurons associated with the endoplasmic reticulum. The novel N-terminal region unique to STEP61 (containing two putative transmembrane domains, two PEST sequences, and two polyproline-rich domains) is responsible for membrane association and also reduces enzymatic activity compared to the cytosolic isoform STEP46.","method":"Transfection experiments in fibroblasts, subcellular fractionation, sucrose density gradients, immunocytochemical labeling, electron microscopy, structural analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (fractionation, density gradients, EM, transfection) in a single focused study establishing both localization and activity differences","pmids":["8987810"],"is_preprint":false},{"year":1999,"finding":"STEP61 is proteolytically cleaved by calpain in response to calcium influx, generating a smaller ~33 kDa isoform (STEP33). Calcium ionophore or thapsigargin treatment triggers cleavage blocked by the calpain inhibitor calpeptin or EGTA. Glutamate exposure in primary neurons also induces this cleavage.","method":"Transfection in NT2/D1 neuronal precursor cells, calcium ionophore treatment, calpain inhibitor experiments, in vitro calpain treatment of STEP61 fusion protein and purified postsynaptic densities, immunoblotting","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution with purified calpain plus cellular experiments with pharmacological inhibitors, multiple orthogonal methods","pmids":["10537058"],"is_preprint":false},{"year":2006,"finding":"STEP binds directly to NMDA receptors in the absence of other synaptic proteins, and STEP's phosphatase activity controls constitutive trafficking and surface expression of NMDARs, affecting receptor functional properties and downstream signaling. Chronic reduction of STEP levels cannot be compensated by other phosphatases.","method":"Direct binding assay, surface biotinylation, electrophysiology, chronic knockdown in neurons","journal":"The European journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding demonstrated and functional consequences of knockdown shown, single lab with multiple methods","pmids":["16819973"],"is_preprint":false},{"year":2006,"finding":"Crystal structures of PTPN5 (STEP) were solved in two distinct crystal forms. PTPN5 crystallized with a sulphate ion near the active site and the WPD loop in a unique conformation ending in a 3(10)-helix not seen in other PTPs. Two classes of small-molecule inhibitors (cyclopenta[c]quinolinecarboxylic acids and 2,5-dimethylpyrrolyl benzoic acids) were identified.","method":"X-ray crystallography (two crystal forms), compound library screening (~24,000 compounds), structure-activity relationship analysis, docking","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structures solved in two forms with active-site characterization; inhibitor identification validated by SAR","pmids":["16441242"],"is_preprint":false},{"year":2007,"finding":"STEP translation is induced by beta1-adrenergic receptor stimulation via co-activation of both the ERK and PI3K-Akt-mTOR pathways (blocked by MEK inhibitor SL327, PI3K inhibitor LY294002, or mTOR inhibitor rapamycin). This is a translation-dependent (not transcription-dependent) mechanism, suggesting STEP participates in a negative feedback loop on ERK.","method":"Pharmacological inhibition in corticostriatal slices and primary neuronal cultures, isoproterenol stimulation, anisomycin/actinomycin D treatment, immunoblotting","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological inhibitors used in two model systems, single lab","pmids":["17623046"],"is_preprint":false},{"year":2010,"finding":"Amyloid-beta increases STEP61 levels in Alzheimer's disease models (Tg2576 mice and cortical cultures) by reducing its ubiquitin-proteasome-mediated degradation. Elevated STEP61 dephosphorylates GluN2B at pTyr1472, reducing NR1/NR2B surface expression. In STEP knockout cultures, Abeta treatment failed to induce NMDA receptor internalization, demonstrating STEP61 is required for Abeta-induced NMDAR endocytosis.","method":"Biotinylation assays for surface receptor expression, STEP KO cultures, proteasome inhibition, ubiquitin conjugate detection, Tg2576 mouse cortex analysis, human AD brain analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO loss-of-function with specific phenotypic readout, multiple orthogonal biochemical methods, validated in mouse model and human tissue","pmids":["20427654"],"is_preprint":false},{"year":2011,"finding":"STEP61 undergoes homodimerization under basal conditions in neurons via intermolecular disulfide bond formation between Cys65 and Cys76 in its N-terminal hydrophobic region. Oxidative stress (H2O2) significantly increases formation of STEP61 dimers and higher-order oligomers, leading to a significant reduction in STEP61 enzymatic activity toward both pNPP and ERK substrates.","method":"In vitro phosphatase activity assays (pNPP and ERK substrates), H2O2 treatment of neurons, site-directed mutagenesis of cysteine residues, immunoblotting under reducing/non-reducing conditions","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — enzymatic activity assays with defined substrates, mutagenesis identifying specific cysteines, single lab but multiple orthogonal methods","pmids":["21198639"],"is_preprint":false},{"year":2011,"finding":"STEP is a brain-specific phosphatase whose targets include ERK1/2, p38, Fyn, Pyk2, NMDARs, and AMPARs. STEP-mediated dephosphorylation of ERK1/2, p38, and Fyn leads to their inactivation, while STEP-mediated dephosphorylation of surface NMDARs and AMPARs promotes their endocytosis. STEP activity is regulated by phosphorylation (by PKA), cleavage, dimerization, ubiquitination, and local translation.","method":"Review synthesizing multiple experimental findings; regulatory mechanisms established by cited original experiments","journal":"Pharmacological reviews","confidence":"Medium","confidence_rationale":"Tier 2 / Strong — comprehensive review integrating replicated findings across multiple labs and methods; confidence limited because this is a review, not primary data","pmids":["22090472"],"is_preprint":false},{"year":2012,"finding":"Pyk2 (proline-rich tyrosine kinase 2) is a direct substrate of STEP. STEP binds to and dephosphorylates Pyk2 at Tyr402. STEP KO mice show enhanced phosphorylation of Pyk2 at Tyr402 and of downstream Pyk2 substrates paxillin and ASAP1. STEP opposes Pyk2 activation after KCl depolarization and blocks Pyk2 translocation to postsynaptic densities.","method":"Co-immunoprecipitation, in vitro phosphatase assay, STEP KO mouse analysis, KCl depolarization of cortical slices, immunoblotting, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro phosphatase assay directly demonstrating dephosphorylation of Pyk2 Tyr402, confirmed in KO mice with multiple substrates","pmids":["22544749"],"is_preprint":false},{"year":2013,"finding":"STEP61 negatively regulates Abeta-mediated ERK/CREB signaling via alpha7 nicotinic acetylcholine receptors. Abeta binding to alpha7 nAChRs increases STEP61 expression and active (dephosphorylated) STEP61; this is blocked by the alpha7 nAChR antagonist alpha-bungarotoxin. Knockdown of STEP61 enhances ERK1/2 and CREB activation in Abeta-treated neurons.","method":"APP/PS1 transgenic mouse model, Abeta1-42 treatment of cortical neurons, alpha-bungarotoxin pharmacology, STEP61 siRNA knockdown, immunoblotting","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic manipulation in two complementary model systems, single lab","pmids":["24123152"],"is_preprint":false},{"year":2014,"finding":"PKA phosphorylates STEP61 at Ser221, inactivating it. During motor skill learning on the rotarod task, phospho-STEP61 (Ser221) levels are differentially modulated in hippocampus, motor cortex, and striatum. Pharmacological inhibition of PKA in dorsal striatum reduces pSTEP61(Ser221), promotes STEP61 activity, and impairs motor learning.","method":"Rotarod behavioral task in mice, intrastriatal injection of PKA inhibitor Rp-cAMPS, immunoblotting for phospho-STEP61 Ser221","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo pharmacological manipulation with behavioral and biochemical readouts, single lab","pmids":["24466306"],"is_preprint":false},{"year":2015,"finding":"Parkin (PARK2 E3 ubiquitin ligase) ubiquitinates STEP61 and regulates its levels through the proteasome. Clinically relevant parkin mutants fail to ubiquitinate STEP61. Acute downregulation of parkin or PARK2 KO in rat striatum elevates STEP61. Elevated STEP61 in PD models is associated with decreased ERK1/2 phosphorylation and pCREB.","method":"Cellular ubiquitination assays with wild-type and mutant parkin, acute parkin knockdown, PARK2 KO rat striatum analysis, MPTP-lesioned mouse model, human sporadic PD brain tissue analysis, immunoblotting","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct ubiquitination assay, multiple genetic models (KD, KO, mutant parkin), human tissue validation, and downstream substrate analysis","pmids":["25583483"],"is_preprint":false},{"year":2015,"finding":"STEP61 levels and activity are regulated by prolonged changes in neuronal activity as part of homeostatic synaptic plasticity. Prolonged activity blockade decreases STEP61 level/activity and increases tyrosine phosphorylation of GluN2B and GluA2 (STEP61 substrates); increasing STEP61 activity blocks synaptic scaling. Prolonged activity enhancement increases STEP61 level/activity and reduces GluN2B/GluA2 phosphorylation in a STEP61-dependent manner.","method":"Rat dissociated hippocampal cultures, activity blockade/enhancement paradigms, immunoblotting, electrophysiology (mEPSC recording), pharmacological manipulation of STEP61","journal":"Molecular brain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple activity paradigms with biochemical and functional readouts, STEP61-dependency established, single lab","pmids":["26391783"],"is_preprint":false},{"year":2015,"finding":"STEP61 inhibition (genetic knockdown or pharmacological TC-2153) prevents PCP-induced reduction of BDNF expression by restoring CREB-dependent BDNF transcription. PCP increases STEP61 levels, which inhibits CREB phosphorylation and downstream BDNF expression; STEP61 knockdown rescues BDNF levels and normalizes PCP-induced behavioral deficits in vivo.","method":"PCP-treated cortical cultures and mice, STEP61 knockdown/TC-2153 pharmacology, CREB phosphorylation analysis, BDNF mRNA/protein measurement, behavioral testing (hyperlocomotion, cognitive tasks)","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological inhibition with transcriptional and behavioral readouts, single lab","pmids":["26450419"],"is_preprint":false},{"year":2016,"finding":"STEP61 binds directly to PSD-95 but not to other PSD-95 family members. PSD-95 expression destabilizes STEP61 via ubiquitination and proteasomal degradation, and excludes STEP61 from the PSD. Knockdown of PSD-95 or PSD-95 KO mice show increased STEP61 in the PSD fraction. Only extrasynaptic (not synaptic) NMDAR expression and currents are increased upon STEP knockdown, consistent with STEP61's exclusion from the PSD by PSD-95.","method":"Co-immunoprecipitation, ubiquitination assay, subcellular fractionation, PSD-95 KO mice, PSD-95 knockdown, electrophysiology (synaptic vs. extrasynaptic NMDAR currents)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct binding assay, ubiquitination assay, KO mouse validation, electrophysiology providing functional correlate; multiple orthogonal methods","pmids":["27457929"],"is_preprint":false},{"year":2016,"finding":"STEP61 is elevated in schizophrenia models (Nrg1+/- mice, ErbB2/4 mice, hiPSC-derived neurons from SZ patients). Elevated STEP61 causes loss of NMDARs from synaptic membranes via dephosphorylation of GluN2B and inactivation of ERK1/2 and Fyn. Genetic reduction or pharmacological inhibition of STEP prevents NMDAR loss and reverses behavioral deficits. The elevated STEP61 reflects reduced ubiquitination and degradation.","method":"Nrg1+/- and ErbB2/4 KO mouse models, hiPSC-derived neurons from SZ patient cohorts, genetic STEP reduction, TC-2153 pharmacological inhibition, surface receptor biotinylation, behavioral testing, ubiquitination assays","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — convergent evidence from multiple mouse models and human hiPSC neurons, genetic and pharmacological rescue with defined molecular mechanism","pmids":["27752082"],"is_preprint":false},{"year":2018,"finding":"A first-in-class small molecule allosteric activator of STEP (PTPN5) was identified that binds to the phosphatase domain at a site distinct from the active site. Allosteric binding was confirmed by X-ray crystallography and 15N NMR. Molecular dynamics simulations indicate activation occurs via a long-range allosteric mechanism. The activator shows selectivity for STEP over other PTPs.","method":"X-ray crystallography, 15N NMR, enzymatic activity assays with selectivity panel, molecular dynamics simulations, fragment screening","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structural confirmation by X-ray and NMR with enzymatic validation and specificity demonstrated; single lab but multiple orthogonal methods","pmids":["30207464"],"is_preprint":false},{"year":2019,"finding":"In rodent inflammatory pain and human spinal cord ex vivo models, BDNF-mediated KCC2-dependent disinhibition downregulates STEP61 activity. Decreased STEP61 activity is necessary and sufficient to prime subsequent phosphorylation and potentiation of GluN2B-NMDARs by BDNF at lamina I synapses. Blocking disinhibition reversed the downregulation of STEP61 and inflammation-mediated behavioral hypersensitivity.","method":"Rodent nerve injury and inflammatory pain models, human ex vivo spinal cord BDNF model, KCC2 blockade, STEP61 knockdown/overexpression, GluN2B phosphorylation assays, electrophysiology, behavioral testing","journal":"Brain","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss- and gain-of-function experiments, multiple model systems (rodent and human), epistasis established between KCC2/disinhibition, STEP61, and GluN2B","pmids":["31135041"],"is_preprint":false},{"year":2015,"finding":"STEP61 tonically interacts with and negatively controls ERK and Fyn kinase activity in spinal dorsal horn neurons under physiological conditions. Impaired GABAergic inhibition disrupts STEP61 interaction with these substrates, allowing ERK and Fyn hyperactivation, subsequent tyrosine phosphorylation and synaptic accumulation of GluN2B-NMDARs, and pain hypersensitivity. Overexpression of wild-type STEP61 blocked bicuculline-induced allodynia and alleviated chronic inflammatory pain.","method":"Intrathecal bicuculline/muscimol administration, co-immunoprecipitation, immunoblotting, immunohistochemistry, STEP61 overexpression (viral), behavioral pain testing","journal":"Anesthesiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP demonstrating interaction, gain-of-function with defined behavioral readout, single lab with multiple methods","pmids":["25478941"],"is_preprint":false}],"current_model":"PTPN5 (STEP/STEP61) is a brain-enriched non-receptor protein tyrosine phosphatase that dephosphorylates and inactivates ERK1/2, p38, Fyn, and Pyk2 kinases, and dephosphorylates GluN2B (Tyr1472) and GluA2 on NMDA and AMPA receptors to promote their endocytosis; STEP61, the membrane-associated isoform, localizes to the endoplasmic reticulum and postsynaptic compartments via its N-terminal transmembrane/PEST domains, opposes synaptic strengthening (LTP) and promotes LTD, and is itself regulated by PKA phosphorylation (Ser221, inactivating), calpain cleavage (calcium-dependent, generating STEP33), oxidative stress-induced disulfide-bonded oligomerization (inactivating), and ubiquitin-proteasome degradation mediated by the E3 ligases parkin and (indirectly) PSD-95, with local translation induced by beta1-adrenergic/ERK/mTOR co-activation providing a negative feedback mechanism."},"narrative":{"mechanistic_narrative":"PTPN5 (STEP) is a brain-enriched non-receptor tyrosine phosphatase that acts as a central brake on synaptic signaling by dephosphorylating and inactivating the kinases ERK1/2, p38, Fyn, and Pyk2 and by dephosphorylating glutamate receptor subunits to drive their endocytosis [PMID:22090472, PMID:22544749]. STEP directly binds NMDA receptors and controls their constitutive surface trafficking, and dephosphorylates GluN2B (pTyr1472) and GluA2 to promote receptor internalization, thereby opposing synaptic strengthening [PMID:16819973, PMID:20427654, PMID:26391783]. The membrane-associated isoform STEP61 is an intrinsic endoplasmic reticulum membrane protein, its unique N-terminal region (transmembrane, PEST, and polyproline domains) conferring membrane association while lowering catalytic activity relative to the cytosolic STEP46 isoform [PMID:8987810]. STEP activity and abundance are tightly controlled: PKA phosphorylation at Ser221 inactivates the enzyme [PMID:24466306], calcium-activated calpain cleaves STEP61 to a ~33 kDa fragment [PMID:10537058], oxidative stress drives inactivating intermolecular disulfide oligomerization via Cys65/Cys76 [PMID:21198639], and ubiquitin-proteasome turnover is mediated by the E3 ligase parkin and promoted by PSD-95, which also excludes STEP61 from the postsynaptic density [PMID:25583483, PMID:27457929]. STEP61 abundance is further set by activity-dependent local translation downstream of beta1-adrenergic/ERK/mTOR signaling, forming a negative feedback loop on ERK [PMID:17623046]. Dysregulated elevation of STEP61 — through impaired ubiquitination — causes pathological NMDAR loss in Alzheimer's disease, Parkinson's disease, and schizophrenia models, while reduced STEP61 activity contributes to inflammatory pain hypersensitivity [PMID:20427654, PMID:25583483, PMID:27752082, PMID:31135041]. Crystallographic and fragment-based studies have defined the active site and an allosteric site, enabling both small-molecule inhibitors and a first-in-class allosteric activator [PMID:16441242, PMID:30207464].","teleology":[{"year":1996,"claim":"Established why STEP61 differs from its cytosolic counterpart by showing its unique N-terminal region targets it to the ER membrane and tunes down its catalytic activity, defining the isoform basis for compartmentalized phosphatase action.","evidence":"Transfection, subcellular fractionation, sucrose gradients, EM and immunocytochemistry in striatal/fibroblast systems","pmids":["8987810"],"confidence":"High","gaps":["Did not identify physiological substrates dephosphorylated at the ER","Functional role of PEST/polyproline domains in turnover not yet tested"]},{"year":1999,"claim":"Answered how calcium signaling acutely controls STEP by showing calpain cleaves STEP61 into STEP33 in response to calcium influx and glutamate, linking the phosphatase to excitatory neurotransmission.","evidence":"Calcium ionophore/thapsigargin treatment, calpain inhibitor and EGTA blockade, in vitro calpain cleavage of fusion protein and PSDs","pmids":["10537058"],"confidence":"High","gaps":["Catalytic activity and substrate specificity of the STEP33 fragment not fully defined","In vivo consequences of cleavage not established"]},{"year":2006,"claim":"Demonstrated that STEP binds NMDARs directly and non-redundantly controls their surface trafficking, establishing receptor regulation as a core function and solving high-resolution structures that defined the active site for drug design.","evidence":"Direct binding assays, surface biotinylation, chronic knockdown electrophysiology; X-ray crystallography in two forms with inhibitor screening","pmids":["16819973","16441242"],"confidence":"High","gaps":["Precise binding interface on the receptor not mapped","Early inhibitors lacked validated cellular selectivity"]},{"year":2007,"claim":"Identified an activity-dependent feedback circuit by showing STEP translation is induced through beta1-adrenergic co-activation of ERK and PI3K-Akt-mTOR pathways, positioning STEP as a negative regulator of ERK signaling.","evidence":"Pharmacological pathway inhibition (SL327, LY294002, rapamycin) plus anisomycin/actinomycin in slices and primary neurons","pmids":["17623046"],"confidence":"Medium","gaps":["mRNA localization machinery not identified","In vivo behavioral relevance of induced translation not shown"]},{"year":2010,"claim":"Connected STEP61 to disease by showing amyloid-beta stabilizes STEP61 by impairing its proteasomal degradation, and that STEP61 is required for Abeta-induced NMDAR internalization, defining a pathogenic mechanism in Alzheimer's models.","evidence":"STEP KO cultures, surface biotinylation, proteasome inhibition, ubiquitin detection, Tg2576 mice and human AD brain","pmids":["20427654"],"confidence":"High","gaps":["E3 ligase responsible for Abeta-sensitive degradation not identified here","Link between receptor loss and cognitive deficit not directly tested"]},{"year":2011,"claim":"Revealed redox regulation of STEP by showing oxidative stress drives inactivating disulfide-bonded oligomerization through Cys65/Cys76, and consolidated the substrate set (ERK, p38, Fyn, Pyk2, NMDARs, AMPARs) and regulatory logic in a synthesis.","evidence":"pNPP/ERK activity assays, H2O2 treatment, cysteine mutagenesis, non-reducing immunoblots; review integration of regulatory mechanisms","pmids":["21198639","22090472"],"confidence":"High","gaps":["Physiological oxidant source in vivo not defined","Reversibility of oligomerization in neurons not quantified"]},{"year":2012,"claim":"Defined Pyk2 as a direct STEP substrate dephosphorylated at Tyr402, extending STEP's reach to a kinase controlling PSD targeting and downstream adhesion signaling.","evidence":"Co-IP, in vitro phosphatase assay, STEP KO mice, KCl depolarization, fractionation showing altered paxillin/ASAP1","pmids":["22544749"],"confidence":"High","gaps":["Stoichiometry of Pyk2 dephosphorylation in vivo not measured","Behavioral consequence of Pyk2 dysregulation not addressed"]},{"year":2013,"claim":"Showed that Abeta acting through alpha7 nicotinic receptors elevates and activates STEP61 to suppress ERK/CREB signaling, linking receptor-level Abeta sensing to STEP-mediated transcriptional dampening.","evidence":"APP/PS1 mice, Abeta-treated neurons, alpha-bungarotoxin pharmacology, STEP61 siRNA, immunoblotting","pmids":["24123152"],"confidence":"Medium","gaps":["Mechanism coupling alpha7 nAChR to STEP61 expression unresolved","Single-lab correlative pathway"]},{"year":2014,"claim":"Established PKA phosphorylation of Ser221 as an inactivating switch with a behavioral role, showing PKA inhibition in striatum raises STEP activity and impairs motor learning.","evidence":"Rotarod task, intrastriatal Rp-cAMPS, phospho-STEP61(Ser221) immunoblotting","pmids":["24466306"],"confidence":"Medium","gaps":["Direct in vivo demonstration of PKA-STEP causality limited to pharmacology","Substrates mediating motor-learning effect not pinpointed"]},{"year":2015,"claim":"Defined parkin as a direct E3 ligase for STEP61 and PSD-95 as a binding partner that both degrades STEP61 and excludes it from the PSD, explaining how STEP61 abundance and synaptic localization are controlled and linking its dysregulation to Parkinson's disease.","evidence":"Ubiquitination assays with WT/mutant parkin, PARK2 KO rat and MPTP models, human PD tissue; PSD-95 co-IP, ubiquitination, KO mice, synaptic vs extrasynaptic NMDAR electrophysiology","pmids":["25583483","27457929"],"confidence":"High","gaps":["Whether parkin and PSD-95 act in the same or parallel degradation routes not resolved","Cooperativity between PKA, calpain and ubiquitin pathways not integrated"]},{"year":2015,"claim":"Implicated STEP61 in homeostatic plasticity and behavior, showing activity-dependent changes in STEP61 set GluN2B/GluA2 phosphorylation during synaptic scaling and that elevated STEP61 suppresses CREB-dependent BDNF transcription, driving PCP-induced deficits.","evidence":"Hippocampal cultures with activity paradigms, mEPSC recording; PCP cultures/mice, CREB and BDNF analysis, knockdown/TC-2153 rescue, behavior","pmids":["26391783","26450419"],"confidence":"Medium","gaps":["Signal coupling neuronal activity to STEP61 level changes not defined","Single-lab behavioral correlations"]},{"year":2015,"claim":"Showed STEP61 tonically restrains ERK and Fyn in spinal dorsal horn neurons, and that loss of GABAergic inhibition disrupts these interactions to drive GluN2B accumulation and pain, establishing STEP61 as an inhibitory gatekeeper of nociceptive plasticity.","evidence":"Intrathecal bicuculline/muscimol, co-IP, immunohistochemistry, viral STEP61 overexpression, behavioral pain testing","pmids":["25478941"],"confidence":"Medium","gaps":["Co-IP interactions not reciprocally validated","Direct substrate dephosphorylation kinetics in spinal neurons not measured"]},{"year":2016,"claim":"Provided convergent evidence that pathological STEP61 elevation, via reduced ubiquitination, causes NMDAR loss and behavioral deficits in schizophrenia models that are reversible by STEP inhibition, generalizing the disease mechanism across NMDAR-hypofunction disorders.","evidence":"Nrg1+/- and ErbB2/4 mice, SZ patient hiPSC neurons, genetic and TC-2153 STEP inhibition, surface biotinylation, behavior, ubiquitination assays","pmids":["27752082"],"confidence":"High","gaps":["Upstream cause of reduced STEP61 ubiquitination in SZ not identified","Translation of TC-2153 efficacy to clinical setting not addressed"]},{"year":2018,"claim":"Achieved pharmacological control over STEP by identifying a selective allosteric activator binding outside the active site, validated structurally and enzymatically, opening a route to enhance STEP activity therapeutically.","evidence":"Fragment screening, X-ray crystallography, 15N NMR, enzymatic selectivity panels, molecular dynamics","pmids":["30207464"],"confidence":"High","gaps":["Cellular and in vivo efficacy of the activator not established","Specificity across full PTP family in cells not shown"]},{"year":2019,"claim":"Demonstrated that BDNF/KCC2-dependent disinhibition downregulates STEP61 activity as a necessary and sufficient step priming GluN2B-NMDAR potentiation in inflammatory pain, establishing STEP61 downregulation as a causal node in nociceptive sensitization.","evidence":"Rodent pain models, human ex vivo spinal cord BDNF model, KCC2 blockade, STEP61 knockdown/overexpression, GluN2B phosphorylation, electrophysiology, behavior","pmids":["31135041"],"confidence":"High","gaps":["Molecular mechanism by which disinhibition lowers STEP61 activity not defined","Therapeutic window of STEP modulation in pain not established"]},{"year":null,"claim":"How the multiple regulatory layers (PKA phosphorylation, calpain cleavage, redox oligomerization, parkin/PSD-95-mediated degradation, and local translation) are integrated and prioritized at individual synapses in real time remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified quantitative model of competing STEP regulatory inputs","Spatiotemporal dynamics of STEP activity at single synapses not measured","Causal hierarchy among regulatory mechanisms in vivo unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[7,8,5,2]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[6,3,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,16]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[14,2]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,12,17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,8,4]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,11,15]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[11,14]}],"complexes":[],"partners":["NMDAR (GLUN2B/GRIN2B)","PSD-95 (DLG4)","PYK2 (PTK2B)","PARK2 (PARKIN)","FYN","MAPK1/ERK"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P54829","full_name":"Tyrosine-protein phosphatase non-receptor type 5","aliases":["Neural-specific protein-tyrosine phosphatase","Striatum-enriched protein-tyrosine phosphatase","STEP"],"length_aa":565,"mass_kda":63.5,"function":"May regulate the activity of several effector molecules involved in synaptic plasticity and neuronal cell survival, including MAPKs, Src family kinases and NMDA receptors","subcellular_location":"Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/P54829/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PTPN5","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PTPN5","total_profiled":1310},"omim":[{"mim_id":"602853","title":"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, R; PTPRR","url":"https://www.omim.org/entry/602853"},{"mim_id":"176879","title":"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 5; PTPN5","url":"https://www.omim.org/entry/176879"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Endoplasmic reticulum","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":301.3}],"url":"https://www.proteinatlas.org/search/PTPN5"},"hgnc":{"alias_symbol":["STEP","PTPSTEP","STEP61"],"prev_symbol":[]},"alphafold":{"accession":"P54829","domains":[{"cath_id":"3.90.190.10","chopping":"274-561","consensus_level":"medium","plddt":94.8742,"start":274,"end":561}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P54829","model_url":"https://alphafold.ebi.ac.uk/files/AF-P54829-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P54829-F1-predicted_aligned_error_v6.png","plddt_mean":72.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PTPN5","jax_strain_url":"https://www.jax.org/strain/search?query=PTPN5"},"sequence":{"accession":"P54829","fasta_url":"https://rest.uniprot.org/uniprotkb/P54829.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P54829/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P54829"}},"corpus_meta":[{"pmid":"32045053","id":"PMC_32045053","title":"From Shape to Function: The Next Step in Bioprinting.","date":"2020","source":"Advanced materials (Deerfield Beach, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/32045053","citation_count":290,"is_preprint":false},{"pmid":"26150935","id":"PMC_26150935","title":"Step-by-step quantitative analysis of focal adhesions.","date":"2014","source":"MethodsX","url":"https://pubmed.ncbi.nlm.nih.gov/26150935","citation_count":237,"is_preprint":false},{"pmid":"31950079","id":"PMC_31950079","title":"Beyond mass spectrometry, the next step in proteomics.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31950079","citation_count":214,"is_preprint":false},{"pmid":"30584096","id":"PMC_30584096","title":"Two-step pathway for isoprenoid synthesis.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30584096","citation_count":199,"is_preprint":false},{"pmid":"33835452","id":"PMC_33835452","title":"Single-Cell RNA Sequencing Analysis: A Step-by-Step Overview.","date":"2021","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/33835452","citation_count":195,"is_preprint":false},{"pmid":"12810111","id":"PMC_12810111","title":"Transitional B cells: step by step towards immune competence.","date":"2003","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12810111","citation_count":184,"is_preprint":false},{"pmid":"20427654","id":"PMC_20427654","title":"Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20427654","citation_count":178,"is_preprint":false},{"pmid":"10320942","id":"PMC_10320942","title":"Cell migration as a five-step cycle.","date":"1999","source":"Biochemical Society symposium","url":"https://pubmed.ncbi.nlm.nih.gov/10320942","citation_count":162,"is_preprint":false},{"pmid":"25274702","id":"PMC_25274702","title":"The meiotic checkpoint network: step-by-step through meiotic prophase.","date":"2014","source":"Cold Spring Harbor perspectives in biology","url":"https://pubmed.ncbi.nlm.nih.gov/25274702","citation_count":155,"is_preprint":false},{"pmid":"26706659","id":"PMC_26706659","title":"A step-by-step protocol for assaying protein carbonylation in biological samples.","date":"2015","source":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26706659","citation_count":145,"is_preprint":false},{"pmid":"20039786","id":"PMC_20039786","title":"DNA interstrand crosslink repair in mammalian cells: step by step.","date":"2010","source":"Critical reviews in biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20039786","citation_count":141,"is_preprint":false},{"pmid":"36209144","id":"PMC_36209144","title":"Mitochondrial event as an ultimate step in ferroptosis.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/36209144","citation_count":134,"is_preprint":false},{"pmid":"22090472","id":"PMC_22090472","title":"Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders.","date":"2011","source":"Pharmacological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/22090472","citation_count":131,"is_preprint":false},{"pmid":"28748501","id":"PMC_28748501","title":"A step-by-step microRNA guide to cancer development and metastasis.","date":"2017","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/28748501","citation_count":126,"is_preprint":false},{"pmid":"25483060","id":"PMC_25483060","title":"Geroconversion: irreversible step to cellular senescence.","date":"2014","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25483060","citation_count":115,"is_preprint":false},{"pmid":"31540135","id":"PMC_31540135","title":"Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process.","date":"2019","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/31540135","citation_count":104,"is_preprint":false},{"pmid":"27457929","id":"PMC_27457929","title":"PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP61.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27457929","citation_count":103,"is_preprint":false},{"pmid":"17919899","id":"PMC_17919899","title":"Taking it step by step: mechanistic insights from structural studies of ubiquitin/ubiquitin-like protein modification pathways.","date":"2007","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/17919899","citation_count":97,"is_preprint":false},{"pmid":"16819973","id":"PMC_16819973","title":"Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP).","date":"2006","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16819973","citation_count":87,"is_preprint":false},{"pmid":"12969317","id":"PMC_12969317","title":"Egress: a receptor-regulated step in lymphocyte trafficking.","date":"2003","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/12969317","citation_count":84,"is_preprint":false},{"pmid":"27563092","id":"PMC_27563092","title":"A 15-step synthesis of (+)-ryanodol.","date":"2016","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/27563092","citation_count":84,"is_preprint":false},{"pmid":"19667012","id":"PMC_19667012","title":"Step-by-step evolution of vertebrate blood coagulation.","date":"2009","source":"Cold Spring Harbor symposia on quantitative biology","url":"https://pubmed.ncbi.nlm.nih.gov/19667012","citation_count":79,"is_preprint":false},{"pmid":"18579596","id":"PMC_18579596","title":"Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity.","date":"2008","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/18579596","citation_count":75,"is_preprint":false},{"pmid":"17591830","id":"PMC_17591830","title":"Dasatinib: a new step in molecular target therapy.","date":"2007","source":"Annals of oncology : official journal of the European Society for Medical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17591830","citation_count":74,"is_preprint":false},{"pmid":"7592562","id":"PMC_7592562","title":"5-Aminolevulinate synthase and the first step of heme biosynthesis.","date":"1995","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/7592562","citation_count":73,"is_preprint":false},{"pmid":"8987810","id":"PMC_8987810","title":"STEP61: a member of a family of brain-enriched PTPs is localized to the endoplasmic reticulum.","date":"1996","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8987810","citation_count":72,"is_preprint":false},{"pmid":"33137199","id":"PMC_33137199","title":"Viral RNA recognition by LGP2 and MDA5, and activation of signaling through step-by-step conformational changes.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33137199","citation_count":72,"is_preprint":false},{"pmid":"32748847","id":"PMC_32748847","title":"Squalene: More than a Step toward Sterols.","date":"2020","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/32748847","citation_count":70,"is_preprint":false},{"pmid":"22544749","id":"PMC_22544749","title":"Striatal-enriched protein-tyrosine phosphatase (STEP) regulates Pyk2 kinase activity.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22544749","citation_count":70,"is_preprint":false},{"pmid":"8875246","id":"PMC_8875246","title":"Myotonic dystrophy: will the real gene please step forward!","date":"1996","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8875246","citation_count":66,"is_preprint":false},{"pmid":"20800474","id":"PMC_20800474","title":"A step-by-step guide to visual circuit assembly in Drosophila.","date":"2010","source":"Current opinion in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/20800474","citation_count":65,"is_preprint":false},{"pmid":"25361949","id":"PMC_25361949","title":"Variability of the reverse transcription step: practical implications.","date":"2014","source":"Clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25361949","citation_count":65,"is_preprint":false},{"pmid":"37131074","id":"PMC_37131074","title":"Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease.","date":"2023","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/37131074","citation_count":64,"is_preprint":false},{"pmid":"32260112","id":"PMC_32260112","title":"An Optimised Step-by-Step Protocol for Measuring Relative Telomere Length.","date":"2020","source":"Methods and protocols","url":"https://pubmed.ncbi.nlm.nih.gov/32260112","citation_count":62,"is_preprint":false},{"pmid":"26059482","id":"PMC_26059482","title":"Gene set analysis: A step-by-step guide.","date":"2015","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26059482","citation_count":61,"is_preprint":false},{"pmid":"14758353","id":"PMC_14758353","title":"A DNA enzyme that mimics the first step of RNA splicing.","date":"2004","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14758353","citation_count":60,"is_preprint":false},{"pmid":"26500250","id":"PMC_26500250","title":"First-Step Mutations during Adaptation Restore the Expression of Hundreds of Genes.","date":"2015","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/26500250","citation_count":59,"is_preprint":false},{"pmid":"16441242","id":"PMC_16441242","title":"Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16441242","citation_count":58,"is_preprint":false},{"pmid":"10764139","id":"PMC_10764139","title":"MUM1: a step ahead toward the understanding of lymphoma histogenesis.","date":"2000","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/10764139","citation_count":58,"is_preprint":false},{"pmid":"16214747","id":"PMC_16214747","title":"Microcoding: the second step in DNA barcoding.","date":"2005","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16214747","citation_count":58,"is_preprint":false},{"pmid":"31135041","id":"PMC_31135041","title":"Loss of STEP61 couples disinhibition to N-methyl-d-aspartate receptor potentiation in rodent and human spinal pain processing.","date":"2019","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31135041","citation_count":52,"is_preprint":false},{"pmid":"26697737","id":"PMC_26697737","title":"Are epigenetic drugs for diabetes and obesity at our door step?","date":"2015","source":"Drug discovery today","url":"https://pubmed.ncbi.nlm.nih.gov/26697737","citation_count":49,"is_preprint":false},{"pmid":"35459559","id":"PMC_35459559","title":"Break-induced replication: unraveling each step.","date":"2022","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/35459559","citation_count":48,"is_preprint":false},{"pmid":"25583483","id":"PMC_25583483","title":"STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25583483","citation_count":48,"is_preprint":false},{"pmid":"32140625","id":"PMC_32140625","title":"Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure.","date":"2020","source":"JACC. Basic to translational science","url":"https://pubmed.ncbi.nlm.nih.gov/32140625","citation_count":48,"is_preprint":false},{"pmid":"11341996","id":"PMC_11341996","title":"Evolution of the two-step model for UV-mutagenesis.","date":"2001","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/11341996","citation_count":47,"is_preprint":false},{"pmid":"27597831","id":"PMC_27597831","title":"Biomarkers in DILI: One More Step Forward.","date":"2016","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27597831","citation_count":46,"is_preprint":false},{"pmid":"34001313","id":"PMC_34001313","title":"Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34001313","citation_count":46,"is_preprint":false},{"pmid":"21954590","id":"PMC_21954590","title":"A review of recent experiments on step-to-step \"hand-off\" of the DNA intermediates in mammalian base excision repair pathways.","date":"2011","source":"Molekuliarnaia biologiia","url":"https://pubmed.ncbi.nlm.nih.gov/21954590","citation_count":45,"is_preprint":false},{"pmid":"31244574","id":"PMC_31244574","title":"Stimulus-Responsive Regulation of Enzyme Activity for One-Step and Multi-Step Syntheses.","date":"2019","source":"Advanced synthesis & catalysis","url":"https://pubmed.ncbi.nlm.nih.gov/31244574","citation_count":41,"is_preprint":false},{"pmid":"26391783","id":"PMC_26391783","title":"Regulation of STEP61 and tyrosine-phosphorylation of NMDA and AMPA receptors during homeostatic synaptic plasticity.","date":"2015","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/26391783","citation_count":40,"is_preprint":false},{"pmid":"21454707","id":"PMC_21454707","title":"Endospanins regulate a postinternalization step of the leptin receptor endocytic pathway.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21454707","citation_count":40,"is_preprint":false},{"pmid":"35422526","id":"PMC_35422526","title":"Step by step: cells with multiple functions in cortical circuit assembly.","date":"2022","source":"Nature reviews. Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35422526","citation_count":38,"is_preprint":false},{"pmid":"24096108","id":"PMC_24096108","title":"Step-by-step mechanism of DNA damage recognition by human 8-oxoguanine DNA glycosylase.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24096108","citation_count":38,"is_preprint":false},{"pmid":"36891986","id":"PMC_36891986","title":"The next step in Mendelian randomization.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/36891986","citation_count":37,"is_preprint":false},{"pmid":"26429146","id":"PMC_26429146","title":"One-Step Protein Conjugation to Upconversion Nanoparticles.","date":"2015","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26429146","citation_count":37,"is_preprint":false},{"pmid":"28094092","id":"PMC_28094092","title":"Step by Step, Cell by Cell: Quantification of the Bacterial Cell Cycle.","date":"2017","source":"Trends in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28094092","citation_count":35,"is_preprint":false},{"pmid":"35939561","id":"PMC_35939561","title":"Transcription factors perform a 2-step search of the nucleus.","date":"2022","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35939561","citation_count":35,"is_preprint":false},{"pmid":"33571704","id":"PMC_33571704","title":"Tau internalization: A complex step in tau propagation.","date":"2021","source":"Ageing research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/33571704","citation_count":33,"is_preprint":false},{"pmid":"10537058","id":"PMC_10537058","title":"Calcium-dependent cleavage of striatal enriched tyrosine phosphatase (STEP).","date":"1999","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10537058","citation_count":33,"is_preprint":false},{"pmid":"33537752","id":"PMC_33537752","title":"Step-by-Step Evolution of Telomeres: Lessons from Yeasts.","date":"2021","source":"Genome biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/33537752","citation_count":32,"is_preprint":false},{"pmid":"28189381","id":"PMC_28189381","title":"RNA Chaperones Step Out of Hfq's Shadow.","date":"2017","source":"Trends in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28189381","citation_count":32,"is_preprint":false},{"pmid":"30207464","id":"PMC_30207464","title":"Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule.","date":"2018","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30207464","citation_count":31,"is_preprint":false},{"pmid":"27752082","id":"PMC_27752082","title":"Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models.","date":"2016","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27752082","citation_count":31,"is_preprint":false},{"pmid":"32289493","id":"PMC_32289493","title":"Protein stability during nebulization: Mind the collection step!","date":"2020","source":"European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V","url":"https://pubmed.ncbi.nlm.nih.gov/32289493","citation_count":31,"is_preprint":false},{"pmid":"32563448","id":"PMC_32563448","title":"Livestock Gene Editing by One-step Embryo Manipulation.","date":"2020","source":"Journal of equine veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/32563448","citation_count":29,"is_preprint":false},{"pmid":"34593005","id":"PMC_34593005","title":"Regulating immune memory and reversing tumor thermotolerance through a step-by-step starving-photothermal therapy.","date":"2021","source":"Journal of nanobiotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/34593005","citation_count":29,"is_preprint":false},{"pmid":"30957296","id":"PMC_30957296","title":"Step-function luminopsins for bimodal prolonged neuromodulation.","date":"2019","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/30957296","citation_count":29,"is_preprint":false},{"pmid":"17870519","id":"PMC_17870519","title":"Step by step development of clinical care pathways for older cancer patients: necessary or desirable?","date":"2007","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/17870519","citation_count":28,"is_preprint":false},{"pmid":"31408693","id":"PMC_31408693","title":"Monosynaptic tracing: a step-by-step protocol.","date":"2019","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/31408693","citation_count":27,"is_preprint":false},{"pmid":"25218562","id":"PMC_25218562","title":"Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders.","date":"2014","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/25218562","citation_count":26,"is_preprint":false},{"pmid":"29651936","id":"PMC_29651936","title":"Mammalian Sperm Protamine Extraction and Analysis: A Step-By-Step Detailed Protocol and Brief Review of Protamine Alterations.","date":"2018","source":"Protein and peptide letters","url":"https://pubmed.ncbi.nlm.nih.gov/29651936","citation_count":26,"is_preprint":false},{"pmid":"24123152","id":"PMC_24123152","title":"Tyrosine phosphatase STEP61 negatively regulates amyloid β-mediated ERK/CREB signaling pathways via α7 nicotinic acetylcholine receptors.","date":"2013","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/24123152","citation_count":25,"is_preprint":false},{"pmid":"32170729","id":"PMC_32170729","title":"Regulation of glutamate receptors by striatal-enriched tyrosine phosphatase 61 (STEP61 ).","date":"2020","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32170729","citation_count":25,"is_preprint":false},{"pmid":"35134123","id":"PMC_35134123","title":"G6b-B regulates an essential step in megakaryocyte maturation.","date":"2022","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/35134123","citation_count":25,"is_preprint":false},{"pmid":"20012578","id":"PMC_20012578","title":"The initiation step of eukaryotic DNA replication.","date":"2010","source":"Sub-cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20012578","citation_count":25,"is_preprint":false},{"pmid":"25431200","id":"PMC_25431200","title":"Transient expression assays in grapevine: a step towards genetic improvement.","date":"2014","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/25431200","citation_count":24,"is_preprint":false},{"pmid":"21198639","id":"PMC_21198639","title":"Oxidative stress-induced oligomerization inhibits the activity of the non-receptor tyrosine phosphatase STEP61.","date":"2011","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21198639","citation_count":24,"is_preprint":false},{"pmid":"28607419","id":"PMC_28607419","title":"Two-step ATP-driven opening of cohesin head.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28607419","citation_count":24,"is_preprint":false},{"pmid":"29884622","id":"PMC_29884622","title":"Two-step mechanism and step-arrest mutants of Runella slithyformis NAD+-dependent tRNA 2'-phosphotransferase Tpt1.","date":"2018","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29884622","citation_count":24,"is_preprint":false},{"pmid":"38674814","id":"PMC_38674814","title":"Seaweed Proteins: A Step towards Sustainability?","date":"2024","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/38674814","citation_count":23,"is_preprint":false},{"pmid":"19641467","id":"PMC_19641467","title":"Bile duct ligation: step-by-step to cholangiocyte inflammatory tumorigenesis.","date":"2010","source":"European journal of gastroenterology & hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/19641467","citation_count":23,"is_preprint":false},{"pmid":"30950601","id":"PMC_30950601","title":"RNA Polymerase: Step-by-Step Kinetics and Mechanism of Transcription Initiation.","date":"2019","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30950601","citation_count":22,"is_preprint":false},{"pmid":"25478941","id":"PMC_25478941","title":"GABAergic inhibition regulated pain sensitization through STEP61 signaling in spinal dorsal horn of mice.","date":"2015","source":"Anesthesiology","url":"https://pubmed.ncbi.nlm.nih.gov/25478941","citation_count":22,"is_preprint":false},{"pmid":"32341126","id":"PMC_32341126","title":"Targeting a critical step in fungal hexosamine biosynthesis.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32341126","citation_count":22,"is_preprint":false},{"pmid":"26450419","id":"PMC_26450419","title":"Inhibition of the tyrosine phosphatase STEP61 restores BDNF expression and reverses motor and cognitive deficits in phencyclidine-treated mice.","date":"2015","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/26450419","citation_count":21,"is_preprint":false},{"pmid":"28699511","id":"PMC_28699511","title":"Striatal-enriched Tyrosine Protein Phosphatase (STEP) in the Mechanisms of Depressive Disorders.","date":"2017","source":"Current protein & peptide science","url":"https://pubmed.ncbi.nlm.nih.gov/28699511","citation_count":21,"is_preprint":false},{"pmid":"38691607","id":"PMC_38691607","title":"The step-by-step assembly mechanism of secreted flavivirus NS1 tetramer and hexamer captured at atomic resolution.","date":"2024","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/38691607","citation_count":21,"is_preprint":false},{"pmid":"27127657","id":"PMC_27127657","title":"Seizure-Induced Regulations of Amyloid-β, STEP61, and STEP61 Substrates Involved in Hippocampal Synaptic Plasticity.","date":"2016","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/27127657","citation_count":19,"is_preprint":false},{"pmid":"32206771","id":"PMC_32206771","title":"Step by step evolution of Indeterminate Domain (IDD) transcriptional regulators: from algae to angiosperms.","date":"2020","source":"Annals of botany","url":"https://pubmed.ncbi.nlm.nih.gov/32206771","citation_count":19,"is_preprint":false},{"pmid":"31269486","id":"PMC_31269486","title":"One-Step verse Step-Up Laparoscopic-Assisted Necrosectomy for Infected Pancreatic Necrosis.","date":"2019","source":"Digestive surgery","url":"https://pubmed.ncbi.nlm.nih.gov/31269486","citation_count":18,"is_preprint":false},{"pmid":"24466306","id":"PMC_24466306","title":"Regulation of tyrosine phosphatase STEP61 by protein kinase A during motor skill learning in mice.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24466306","citation_count":17,"is_preprint":false},{"pmid":"35327450","id":"PMC_35327450","title":"Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/35327450","citation_count":17,"is_preprint":false},{"pmid":"25303338","id":"PMC_25303338","title":"Enhanced sampling simulations of DNA step parameters.","date":"2014","source":"Journal of computational chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25303338","citation_count":17,"is_preprint":false},{"pmid":"33467597","id":"PMC_33467597","title":"Breakdown of Filamentous Myofibrils by the UPS-Step by Step.","date":"2021","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33467597","citation_count":16,"is_preprint":false},{"pmid":"17623046","id":"PMC_17623046","title":"Translation of striatal-enriched protein tyrosine phosphatase (STEP) after beta1-adrenergic receptor stimulation.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17623046","citation_count":16,"is_preprint":false},{"pmid":"37821701","id":"PMC_37821701","title":"Structures illustrate step-by-step mitochondrial transcription initiation.","date":"2023","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/37821701","citation_count":15,"is_preprint":false},{"pmid":"26872063","id":"PMC_26872063","title":"Missense Variant in MAPK Inactivator PTPN5 Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26872063","citation_count":15,"is_preprint":false},{"pmid":"34356863","id":"PMC_34356863","title":"Metabolic Phenotypes and Step by Step Evolution of Type 2 Diabetes: A New Paradigm.","date":"2021","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/34356863","citation_count":15,"is_preprint":false},{"pmid":"34045924","id":"PMC_34045924","title":"The Journey from Two-Step to Multi-Step Phosphorelay Signaling Systems.","date":"2021","source":"Current genomics","url":"https://pubmed.ncbi.nlm.nih.gov/34045924","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42730,"output_tokens":5430,"usd":0.10482,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13932,"output_tokens":5389,"usd":0.102193,"stage2_stop_reason":"end_turn"},"total_usd":0.207013,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"STEP61 is an intrinsic membrane protein of striatal neurons associated with the endoplasmic reticulum. The novel N-terminal region unique to STEP61 (containing two putative transmembrane domains, two PEST sequences, and two polyproline-rich domains) is responsible for membrane association and also reduces enzymatic activity compared to the cytosolic isoform STEP46.\",\n      \"method\": \"Transfection experiments in fibroblasts, subcellular fractionation, sucrose density gradients, immunocytochemical labeling, electron microscopy, structural analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (fractionation, density gradients, EM, transfection) in a single focused study establishing both localization and activity differences\",\n      \"pmids\": [\"8987810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"STEP61 is proteolytically cleaved by calpain in response to calcium influx, generating a smaller ~33 kDa isoform (STEP33). Calcium ionophore or thapsigargin treatment triggers cleavage blocked by the calpain inhibitor calpeptin or EGTA. Glutamate exposure in primary neurons also induces this cleavage.\",\n      \"method\": \"Transfection in NT2/D1 neuronal precursor cells, calcium ionophore treatment, calpain inhibitor experiments, in vitro calpain treatment of STEP61 fusion protein and purified postsynaptic densities, immunoblotting\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution with purified calpain plus cellular experiments with pharmacological inhibitors, multiple orthogonal methods\",\n      \"pmids\": [\"10537058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"STEP binds directly to NMDA receptors in the absence of other synaptic proteins, and STEP's phosphatase activity controls constitutive trafficking and surface expression of NMDARs, affecting receptor functional properties and downstream signaling. Chronic reduction of STEP levels cannot be compensated by other phosphatases.\",\n      \"method\": \"Direct binding assay, surface biotinylation, electrophysiology, chronic knockdown in neurons\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding demonstrated and functional consequences of knockdown shown, single lab with multiple methods\",\n      \"pmids\": [\"16819973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Crystal structures of PTPN5 (STEP) were solved in two distinct crystal forms. PTPN5 crystallized with a sulphate ion near the active site and the WPD loop in a unique conformation ending in a 3(10)-helix not seen in other PTPs. Two classes of small-molecule inhibitors (cyclopenta[c]quinolinecarboxylic acids and 2,5-dimethylpyrrolyl benzoic acids) were identified.\",\n      \"method\": \"X-ray crystallography (two crystal forms), compound library screening (~24,000 compounds), structure-activity relationship analysis, docking\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structures solved in two forms with active-site characterization; inhibitor identification validated by SAR\",\n      \"pmids\": [\"16441242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"STEP translation is induced by beta1-adrenergic receptor stimulation via co-activation of both the ERK and PI3K-Akt-mTOR pathways (blocked by MEK inhibitor SL327, PI3K inhibitor LY294002, or mTOR inhibitor rapamycin). This is a translation-dependent (not transcription-dependent) mechanism, suggesting STEP participates in a negative feedback loop on ERK.\",\n      \"method\": \"Pharmacological inhibition in corticostriatal slices and primary neuronal cultures, isoproterenol stimulation, anisomycin/actinomycin D treatment, immunoblotting\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological inhibitors used in two model systems, single lab\",\n      \"pmids\": [\"17623046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Amyloid-beta increases STEP61 levels in Alzheimer's disease models (Tg2576 mice and cortical cultures) by reducing its ubiquitin-proteasome-mediated degradation. Elevated STEP61 dephosphorylates GluN2B at pTyr1472, reducing NR1/NR2B surface expression. In STEP knockout cultures, Abeta treatment failed to induce NMDA receptor internalization, demonstrating STEP61 is required for Abeta-induced NMDAR endocytosis.\",\n      \"method\": \"Biotinylation assays for surface receptor expression, STEP KO cultures, proteasome inhibition, ubiquitin conjugate detection, Tg2576 mouse cortex analysis, human AD brain analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO loss-of-function with specific phenotypic readout, multiple orthogonal biochemical methods, validated in mouse model and human tissue\",\n      \"pmids\": [\"20427654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"STEP61 undergoes homodimerization under basal conditions in neurons via intermolecular disulfide bond formation between Cys65 and Cys76 in its N-terminal hydrophobic region. Oxidative stress (H2O2) significantly increases formation of STEP61 dimers and higher-order oligomers, leading to a significant reduction in STEP61 enzymatic activity toward both pNPP and ERK substrates.\",\n      \"method\": \"In vitro phosphatase activity assays (pNPP and ERK substrates), H2O2 treatment of neurons, site-directed mutagenesis of cysteine residues, immunoblotting under reducing/non-reducing conditions\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — enzymatic activity assays with defined substrates, mutagenesis identifying specific cysteines, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"21198639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"STEP is a brain-specific phosphatase whose targets include ERK1/2, p38, Fyn, Pyk2, NMDARs, and AMPARs. STEP-mediated dephosphorylation of ERK1/2, p38, and Fyn leads to their inactivation, while STEP-mediated dephosphorylation of surface NMDARs and AMPARs promotes their endocytosis. STEP activity is regulated by phosphorylation (by PKA), cleavage, dimerization, ubiquitination, and local translation.\",\n      \"method\": \"Review synthesizing multiple experimental findings; regulatory mechanisms established by cited original experiments\",\n      \"journal\": \"Pharmacological reviews\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Strong — comprehensive review integrating replicated findings across multiple labs and methods; confidence limited because this is a review, not primary data\",\n      \"pmids\": [\"22090472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Pyk2 (proline-rich tyrosine kinase 2) is a direct substrate of STEP. STEP binds to and dephosphorylates Pyk2 at Tyr402. STEP KO mice show enhanced phosphorylation of Pyk2 at Tyr402 and of downstream Pyk2 substrates paxillin and ASAP1. STEP opposes Pyk2 activation after KCl depolarization and blocks Pyk2 translocation to postsynaptic densities.\",\n      \"method\": \"Co-immunoprecipitation, in vitro phosphatase assay, STEP KO mouse analysis, KCl depolarization of cortical slices, immunoblotting, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro phosphatase assay directly demonstrating dephosphorylation of Pyk2 Tyr402, confirmed in KO mice with multiple substrates\",\n      \"pmids\": [\"22544749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"STEP61 negatively regulates Abeta-mediated ERK/CREB signaling via alpha7 nicotinic acetylcholine receptors. Abeta binding to alpha7 nAChRs increases STEP61 expression and active (dephosphorylated) STEP61; this is blocked by the alpha7 nAChR antagonist alpha-bungarotoxin. Knockdown of STEP61 enhances ERK1/2 and CREB activation in Abeta-treated neurons.\",\n      \"method\": \"APP/PS1 transgenic mouse model, Abeta1-42 treatment of cortical neurons, alpha-bungarotoxin pharmacology, STEP61 siRNA knockdown, immunoblotting\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic manipulation in two complementary model systems, single lab\",\n      \"pmids\": [\"24123152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PKA phosphorylates STEP61 at Ser221, inactivating it. During motor skill learning on the rotarod task, phospho-STEP61 (Ser221) levels are differentially modulated in hippocampus, motor cortex, and striatum. Pharmacological inhibition of PKA in dorsal striatum reduces pSTEP61(Ser221), promotes STEP61 activity, and impairs motor learning.\",\n      \"method\": \"Rotarod behavioral task in mice, intrastriatal injection of PKA inhibitor Rp-cAMPS, immunoblotting for phospho-STEP61 Ser221\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo pharmacological manipulation with behavioral and biochemical readouts, single lab\",\n      \"pmids\": [\"24466306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Parkin (PARK2 E3 ubiquitin ligase) ubiquitinates STEP61 and regulates its levels through the proteasome. Clinically relevant parkin mutants fail to ubiquitinate STEP61. Acute downregulation of parkin or PARK2 KO in rat striatum elevates STEP61. Elevated STEP61 in PD models is associated with decreased ERK1/2 phosphorylation and pCREB.\",\n      \"method\": \"Cellular ubiquitination assays with wild-type and mutant parkin, acute parkin knockdown, PARK2 KO rat striatum analysis, MPTP-lesioned mouse model, human sporadic PD brain tissue analysis, immunoblotting\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct ubiquitination assay, multiple genetic models (KD, KO, mutant parkin), human tissue validation, and downstream substrate analysis\",\n      \"pmids\": [\"25583483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"STEP61 levels and activity are regulated by prolonged changes in neuronal activity as part of homeostatic synaptic plasticity. Prolonged activity blockade decreases STEP61 level/activity and increases tyrosine phosphorylation of GluN2B and GluA2 (STEP61 substrates); increasing STEP61 activity blocks synaptic scaling. Prolonged activity enhancement increases STEP61 level/activity and reduces GluN2B/GluA2 phosphorylation in a STEP61-dependent manner.\",\n      \"method\": \"Rat dissociated hippocampal cultures, activity blockade/enhancement paradigms, immunoblotting, electrophysiology (mEPSC recording), pharmacological manipulation of STEP61\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple activity paradigms with biochemical and functional readouts, STEP61-dependency established, single lab\",\n      \"pmids\": [\"26391783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"STEP61 inhibition (genetic knockdown or pharmacological TC-2153) prevents PCP-induced reduction of BDNF expression by restoring CREB-dependent BDNF transcription. PCP increases STEP61 levels, which inhibits CREB phosphorylation and downstream BDNF expression; STEP61 knockdown rescues BDNF levels and normalizes PCP-induced behavioral deficits in vivo.\",\n      \"method\": \"PCP-treated cortical cultures and mice, STEP61 knockdown/TC-2153 pharmacology, CREB phosphorylation analysis, BDNF mRNA/protein measurement, behavioral testing (hyperlocomotion, cognitive tasks)\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological inhibition with transcriptional and behavioral readouts, single lab\",\n      \"pmids\": [\"26450419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"STEP61 binds directly to PSD-95 but not to other PSD-95 family members. PSD-95 expression destabilizes STEP61 via ubiquitination and proteasomal degradation, and excludes STEP61 from the PSD. Knockdown of PSD-95 or PSD-95 KO mice show increased STEP61 in the PSD fraction. Only extrasynaptic (not synaptic) NMDAR expression and currents are increased upon STEP knockdown, consistent with STEP61's exclusion from the PSD by PSD-95.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, subcellular fractionation, PSD-95 KO mice, PSD-95 knockdown, electrophysiology (synaptic vs. extrasynaptic NMDAR currents)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct binding assay, ubiquitination assay, KO mouse validation, electrophysiology providing functional correlate; multiple orthogonal methods\",\n      \"pmids\": [\"27457929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"STEP61 is elevated in schizophrenia models (Nrg1+/- mice, ErbB2/4 mice, hiPSC-derived neurons from SZ patients). Elevated STEP61 causes loss of NMDARs from synaptic membranes via dephosphorylation of GluN2B and inactivation of ERK1/2 and Fyn. Genetic reduction or pharmacological inhibition of STEP prevents NMDAR loss and reverses behavioral deficits. The elevated STEP61 reflects reduced ubiquitination and degradation.\",\n      \"method\": \"Nrg1+/- and ErbB2/4 KO mouse models, hiPSC-derived neurons from SZ patient cohorts, genetic STEP reduction, TC-2153 pharmacological inhibition, surface receptor biotinylation, behavioral testing, ubiquitination assays\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — convergent evidence from multiple mouse models and human hiPSC neurons, genetic and pharmacological rescue with defined molecular mechanism\",\n      \"pmids\": [\"27752082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A first-in-class small molecule allosteric activator of STEP (PTPN5) was identified that binds to the phosphatase domain at a site distinct from the active site. Allosteric binding was confirmed by X-ray crystallography and 15N NMR. Molecular dynamics simulations indicate activation occurs via a long-range allosteric mechanism. The activator shows selectivity for STEP over other PTPs.\",\n      \"method\": \"X-ray crystallography, 15N NMR, enzymatic activity assays with selectivity panel, molecular dynamics simulations, fragment screening\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural confirmation by X-ray and NMR with enzymatic validation and specificity demonstrated; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"30207464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In rodent inflammatory pain and human spinal cord ex vivo models, BDNF-mediated KCC2-dependent disinhibition downregulates STEP61 activity. Decreased STEP61 activity is necessary and sufficient to prime subsequent phosphorylation and potentiation of GluN2B-NMDARs by BDNF at lamina I synapses. Blocking disinhibition reversed the downregulation of STEP61 and inflammation-mediated behavioral hypersensitivity.\",\n      \"method\": \"Rodent nerve injury and inflammatory pain models, human ex vivo spinal cord BDNF model, KCC2 blockade, STEP61 knockdown/overexpression, GluN2B phosphorylation assays, electrophysiology, behavioral testing\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss- and gain-of-function experiments, multiple model systems (rodent and human), epistasis established between KCC2/disinhibition, STEP61, and GluN2B\",\n      \"pmids\": [\"31135041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"STEP61 tonically interacts with and negatively controls ERK and Fyn kinase activity in spinal dorsal horn neurons under physiological conditions. Impaired GABAergic inhibition disrupts STEP61 interaction with these substrates, allowing ERK and Fyn hyperactivation, subsequent tyrosine phosphorylation and synaptic accumulation of GluN2B-NMDARs, and pain hypersensitivity. Overexpression of wild-type STEP61 blocked bicuculline-induced allodynia and alleviated chronic inflammatory pain.\",\n      \"method\": \"Intrathecal bicuculline/muscimol administration, co-immunoprecipitation, immunoblotting, immunohistochemistry, STEP61 overexpression (viral), behavioral pain testing\",\n      \"journal\": \"Anesthesiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP demonstrating interaction, gain-of-function with defined behavioral readout, single lab with multiple methods\",\n      \"pmids\": [\"25478941\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PTPN5 (STEP/STEP61) is a brain-enriched non-receptor protein tyrosine phosphatase that dephosphorylates and inactivates ERK1/2, p38, Fyn, and Pyk2 kinases, and dephosphorylates GluN2B (Tyr1472) and GluA2 on NMDA and AMPA receptors to promote their endocytosis; STEP61, the membrane-associated isoform, localizes to the endoplasmic reticulum and postsynaptic compartments via its N-terminal transmembrane/PEST domains, opposes synaptic strengthening (LTP) and promotes LTD, and is itself regulated by PKA phosphorylation (Ser221, inactivating), calpain cleavage (calcium-dependent, generating STEP33), oxidative stress-induced disulfide-bonded oligomerization (inactivating), and ubiquitin-proteasome degradation mediated by the E3 ligases parkin and (indirectly) PSD-95, with local translation induced by beta1-adrenergic/ERK/mTOR co-activation providing a negative feedback mechanism.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PTPN5 (STEP) is a brain-enriched non-receptor tyrosine phosphatase that acts as a central brake on synaptic signaling by dephosphorylating and inactivating the kinases ERK1/2, p38, Fyn, and Pyk2 and by dephosphorylating glutamate receptor subunits to drive their endocytosis [#7, #8]. STEP directly binds NMDA receptors and controls their constitutive surface trafficking, and dephosphorylates GluN2B (pTyr1472) and GluA2 to promote receptor internalization, thereby opposing synaptic strengthening [#2, #5, #12]. The membrane-associated isoform STEP61 is an intrinsic endoplasmic reticulum membrane protein, its unique N-terminal region (transmembrane, PEST, and polyproline domains) conferring membrane association while lowering catalytic activity relative to the cytosolic STEP46 isoform [#0]. STEP activity and abundance are tightly controlled: PKA phosphorylation at Ser221 inactivates the enzyme [#10], calcium-activated calpain cleaves STEP61 to a ~33 kDa fragment [#1], oxidative stress drives inactivating intermolecular disulfide oligomerization via Cys65/Cys76 [#6], and ubiquitin-proteasome turnover is mediated by the E3 ligase parkin and promoted by PSD-95, which also excludes STEP61 from the postsynaptic density [#11, #14]. STEP61 abundance is further set by activity-dependent local translation downstream of beta1-adrenergic/ERK/mTOR signaling, forming a negative feedback loop on ERK [#4]. Dysregulated elevation of STEP61 — through impaired ubiquitination — causes pathological NMDAR loss in Alzheimer's disease, Parkinson's disease, and schizophrenia models, while reduced STEP61 activity contributes to inflammatory pain hypersensitivity [#5, #11, #15, #17]. Crystallographic and fragment-based studies have defined the active site and an allosteric site, enabling both small-molecule inhibitors and a first-in-class allosteric activator [#3, #16].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established why STEP61 differs from its cytosolic counterpart by showing its unique N-terminal region targets it to the ER membrane and tunes down its catalytic activity, defining the isoform basis for compartmentalized phosphatase action.\",\n      \"evidence\": \"Transfection, subcellular fractionation, sucrose gradients, EM and immunocytochemistry in striatal/fibroblast systems\",\n      \"pmids\": [\"8987810\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify physiological substrates dephosphorylated at the ER\", \"Functional role of PEST/polyproline domains in turnover not yet tested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Answered how calcium signaling acutely controls STEP by showing calpain cleaves STEP61 into STEP33 in response to calcium influx and glutamate, linking the phosphatase to excitatory neurotransmission.\",\n      \"evidence\": \"Calcium ionophore/thapsigargin treatment, calpain inhibitor and EGTA blockade, in vitro calpain cleavage of fusion protein and PSDs\",\n      \"pmids\": [\"10537058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic activity and substrate specificity of the STEP33 fragment not fully defined\", \"In vivo consequences of cleavage not established\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated that STEP binds NMDARs directly and non-redundantly controls their surface trafficking, establishing receptor regulation as a core function and solving high-resolution structures that defined the active site for drug design.\",\n      \"evidence\": \"Direct binding assays, surface biotinylation, chronic knockdown electrophysiology; X-ray crystallography in two forms with inhibitor screening\",\n      \"pmids\": [\"16819973\", \"16441242\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise binding interface on the receptor not mapped\", \"Early inhibitors lacked validated cellular selectivity\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified an activity-dependent feedback circuit by showing STEP translation is induced through beta1-adrenergic co-activation of ERK and PI3K-Akt-mTOR pathways, positioning STEP as a negative regulator of ERK signaling.\",\n      \"evidence\": \"Pharmacological pathway inhibition (SL327, LY294002, rapamycin) plus anisomycin/actinomycin in slices and primary neurons\",\n      \"pmids\": [\"17623046\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"mRNA localization machinery not identified\", \"In vivo behavioral relevance of induced translation not shown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Connected STEP61 to disease by showing amyloid-beta stabilizes STEP61 by impairing its proteasomal degradation, and that STEP61 is required for Abeta-induced NMDAR internalization, defining a pathogenic mechanism in Alzheimer's models.\",\n      \"evidence\": \"STEP KO cultures, surface biotinylation, proteasome inhibition, ubiquitin detection, Tg2576 mice and human AD brain\",\n      \"pmids\": [\"20427654\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase responsible for Abeta-sensitive degradation not identified here\", \"Link between receptor loss and cognitive deficit not directly tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Revealed redox regulation of STEP by showing oxidative stress drives inactivating disulfide-bonded oligomerization through Cys65/Cys76, and consolidated the substrate set (ERK, p38, Fyn, Pyk2, NMDARs, AMPARs) and regulatory logic in a synthesis.\",\n      \"evidence\": \"pNPP/ERK activity assays, H2O2 treatment, cysteine mutagenesis, non-reducing immunoblots; review integration of regulatory mechanisms\",\n      \"pmids\": [\"21198639\", \"22090472\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological oxidant source in vivo not defined\", \"Reversibility of oligomerization in neurons not quantified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined Pyk2 as a direct STEP substrate dephosphorylated at Tyr402, extending STEP's reach to a kinase controlling PSD targeting and downstream adhesion signaling.\",\n      \"evidence\": \"Co-IP, in vitro phosphatase assay, STEP KO mice, KCl depolarization, fractionation showing altered paxillin/ASAP1\",\n      \"pmids\": [\"22544749\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of Pyk2 dephosphorylation in vivo not measured\", \"Behavioral consequence of Pyk2 dysregulation not addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed that Abeta acting through alpha7 nicotinic receptors elevates and activates STEP61 to suppress ERK/CREB signaling, linking receptor-level Abeta sensing to STEP-mediated transcriptional dampening.\",\n      \"evidence\": \"APP/PS1 mice, Abeta-treated neurons, alpha-bungarotoxin pharmacology, STEP61 siRNA, immunoblotting\",\n      \"pmids\": [\"24123152\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism coupling alpha7 nAChR to STEP61 expression unresolved\", \"Single-lab correlative pathway\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established PKA phosphorylation of Ser221 as an inactivating switch with a behavioral role, showing PKA inhibition in striatum raises STEP activity and impairs motor learning.\",\n      \"evidence\": \"Rotarod task, intrastriatal Rp-cAMPS, phospho-STEP61(Ser221) immunoblotting\",\n      \"pmids\": [\"24466306\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct in vivo demonstration of PKA-STEP causality limited to pharmacology\", \"Substrates mediating motor-learning effect not pinpointed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined parkin as a direct E3 ligase for STEP61 and PSD-95 as a binding partner that both degrades STEP61 and excludes it from the PSD, explaining how STEP61 abundance and synaptic localization are controlled and linking its dysregulation to Parkinson's disease.\",\n      \"evidence\": \"Ubiquitination assays with WT/mutant parkin, PARK2 KO rat and MPTP models, human PD tissue; PSD-95 co-IP, ubiquitination, KO mice, synaptic vs extrasynaptic NMDAR electrophysiology\",\n      \"pmids\": [\"25583483\", \"27457929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether parkin and PSD-95 act in the same or parallel degradation routes not resolved\", \"Cooperativity between PKA, calpain and ubiquitin pathways not integrated\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Implicated STEP61 in homeostatic plasticity and behavior, showing activity-dependent changes in STEP61 set GluN2B/GluA2 phosphorylation during synaptic scaling and that elevated STEP61 suppresses CREB-dependent BDNF transcription, driving PCP-induced deficits.\",\n      \"evidence\": \"Hippocampal cultures with activity paradigms, mEPSC recording; PCP cultures/mice, CREB and BDNF analysis, knockdown/TC-2153 rescue, behavior\",\n      \"pmids\": [\"26391783\", \"26450419\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signal coupling neuronal activity to STEP61 level changes not defined\", \"Single-lab behavioral correlations\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed STEP61 tonically restrains ERK and Fyn in spinal dorsal horn neurons, and that loss of GABAergic inhibition disrupts these interactions to drive GluN2B accumulation and pain, establishing STEP61 as an inhibitory gatekeeper of nociceptive plasticity.\",\n      \"evidence\": \"Intrathecal bicuculline/muscimol, co-IP, immunohistochemistry, viral STEP61 overexpression, behavioral pain testing\",\n      \"pmids\": [\"25478941\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP interactions not reciprocally validated\", \"Direct substrate dephosphorylation kinetics in spinal neurons not measured\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided convergent evidence that pathological STEP61 elevation, via reduced ubiquitination, causes NMDAR loss and behavioral deficits in schizophrenia models that are reversible by STEP inhibition, generalizing the disease mechanism across NMDAR-hypofunction disorders.\",\n      \"evidence\": \"Nrg1+/- and ErbB2/4 mice, SZ patient hiPSC neurons, genetic and TC-2153 STEP inhibition, surface biotinylation, behavior, ubiquitination assays\",\n      \"pmids\": [\"27752082\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream cause of reduced STEP61 ubiquitination in SZ not identified\", \"Translation of TC-2153 efficacy to clinical setting not addressed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Achieved pharmacological control over STEP by identifying a selective allosteric activator binding outside the active site, validated structurally and enzymatically, opening a route to enhance STEP activity therapeutically.\",\n      \"evidence\": \"Fragment screening, X-ray crystallography, 15N NMR, enzymatic selectivity panels, molecular dynamics\",\n      \"pmids\": [\"30207464\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular and in vivo efficacy of the activator not established\", \"Specificity across full PTP family in cells not shown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated that BDNF/KCC2-dependent disinhibition downregulates STEP61 activity as a necessary and sufficient step priming GluN2B-NMDAR potentiation in inflammatory pain, establishing STEP61 downregulation as a causal node in nociceptive sensitization.\",\n      \"evidence\": \"Rodent pain models, human ex vivo spinal cord BDNF model, KCC2 blockade, STEP61 knockdown/overexpression, GluN2B phosphorylation, electrophysiology, behavior\",\n      \"pmids\": [\"31135041\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which disinhibition lowers STEP61 activity not defined\", \"Therapeutic window of STEP modulation in pain not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple regulatory layers (PKA phosphorylation, calpain cleavage, redox oligomerization, parkin/PSD-95-mediated degradation, and local translation) are integrated and prioritized at individual synapses in real time remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified quantitative model of competing STEP regulatory inputs\", \"Spatiotemporal dynamics of STEP activity at single synapses not measured\", \"Causal hierarchy among regulatory mechanisms in vivo unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [7, 8, 5, 2]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [6, 3, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [14, 2]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 12, 17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 8, 4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 11, 15]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [11, 14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NMDAR (GluN2B/GRIN2B)\", \"PSD-95 (DLG4)\", \"Pyk2 (PTK2B)\", \"PARK2 (parkin)\", \"Fyn\", \"MAPK1/ERK\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}